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Abstract
Most cancerous lesions are derived from potentially malignant oral disorders 
(PMOD). The World Health Organization (WHO) points out the following lesions 
as the main PMOD: leukoplakia, erythroplakia, actinic cheilitis, submucous 
fibrosis, and lichen planus. Leukoplakias are white plaques or spots that cannot be 
removed by scraping, and these lesions aren’t characterized clinically or patho-
logically like any other diseases. Erythroplakias are red lesions of the oral mucosa 
that also cannot be characterized clinically or pathologically as another definable 
disease. Actinic cheilitis is an injury that affects the vermilion of the lower lip and 
has this anatomical location due to its etiological factor, which is the progressive 
and excessive exposure to ultraviolet rays of sunlight. Submucous fibrosis is a 
chronic disease of the mouth that presents as an inflammatory subepithelial reac-
tion, followed by an alteration in the submucous fibroelastic tissue. Lichen planus 
is a dermatological disease characterized by white patches or striations, symmetri-
cal and bilateral, and its treatment is basically done with topical corticosteroids.
Keywords: potentially malignant oral disorders, leukoplakia, erythroplasia,  
actinic cheilitis, lichen planus
1. Introduction
Head and neck cancer is a worldwide public health problem, and according to the 
International Agency for Research on Cancer (IARC) in 2018, 1,454,892 new cases of 
head and neck cancer worldwide have been estimated. When all the sites involving 
the head and neck region added, these tumors occupy the third place, behind only 
the lung tumors (2,093,876) and the breast (2,088,849) [1]. By analyzing the sexes 
separately, head and neck tumors are the fourth most common cause of cancer in men 
(796,946 cases), behind lung, prostate, and colorectal cancer. In women, they are also 
the fourth most common cause (657,966 cases), behind breast, colorectal, and lung 
cancer, and thyroid tumors are the most frequent in this population (436,344 cases). 
In Brazil, according to the National Cancer Institute (INCA), there is an estimated 
11,200 new cases of cancer of the oral cavity in men and 3,500 in women for each year 
of the 2018–2019 biennium, placing this neoplasm in fifth place in the prevalence [2].
The incidence can change by region of the world. In developing countries, in 
men, lip and oral cavity cancer alone is the third in incidence, partly because of the 
high disease rate in India, which accounts for 36% of the population of countries 
with low human development index (IDH) [2].
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Understanding the world statistics on cancer, more specifically on head and neck 
cancer, is essential in order to propose measures of prevention and early diagnosis, 
such as anti-smoking policies, HPV vaccination, and improvement of the oral 
health and diet of the population. Such measures would have a significant impact 
on the incidence and mortality of this disease [2].
Among the risk factors, potentially malignant oral disorders have a prominence, 
since they are generally the first indication of the disease [3]. The World Health 
Organization (WHO), in its latest publication, has defined PMSD as clinical presen-
tations that carry a risk of developing oral cavity cancer, a clinically defined precur-
sor lesion or clinically normal oral mucosa [4]. The WHO identifies as PMOD the 
following disorders: erythroplakia, erythroleukoplakia, leukoplakia, oral submu-
cous fibrosis (OSF), congenital dyskeratosis, smokeless tobacco keratosis, palatine 
lesions associated with reverse smoking, chronic candidiasis, lichen planus, discoid 
lupus erythematosus, glossitis syphilitic, and actinic cheilitis. In this chapter, we 
will discuss the most common PMODs with the highest potential for malignant 
transformation, which are leukoplakias, erythroplasias, oral lichen planus, actinic 
cheilitis and oral submucous fibrosis [1, 4].
2. Leukoplakia
According to the WHO, leukoplakia is defined as a white, variable-risk plaque, 
excluding (other) known diseases or disorders that do not carry an increased risk 
of cancer; therefore, the nomenclature is restricted only to the clinical aspect and 
histological changes. Due to the fact that its clinical diagnosis is basically made 
by exclusion, this disorder makes a differential diagnosis with other well-known 
lesions and with very similar clinical characteristics such as pseudomembranous 
candidiasis, Lichen planus, leukoedema, and lupus erythematosus [5]. The specific 
causative factors of leukoplakia are still unknown; however, it is known that the 
smoking habit is closely linked to the progression of leukoplakia. In addition, other 
risk factors have been associated with the development of this disorder, the con-
sumption of alcohol that would act synergistically with tobacco, trauma, as well as 
infestations of microorganisms such as human papillomavirus (HPV) [6].
Oral leukoplakia is the most common PMOD, presenting a prevalence of 1% 
and an annual malignant transformation risk of 2%. It is found in equal proportion 
between men and women, rarely occurs in the first two decades of life, and is more 
prevalent among individuals, and this is their main etiological factor. The anatomical 
sites in which about 70% of the leukoplakia are found are jugal mucosa, gingiva, 
and vermillion of the lip; however, lesions located on the tongue and floor of the 
mouth contribute to over 90% of the cases that present some level of dysplasia or 
even a carcinoma [6–8].
Clinically the leukoplakias are subdivided into homogeneous and nonhomo-
geneous. Homogeneous leukoplakias are characterized as uniformly flat and thin 
lesions that have a low percentage of malignant transformation, as well as spontane-
ous regression after elimination of risk factors, especially smoking habit (Figure 1) 
[3, 9]. Nonhomogeneous leukoplakias are described as white and red lesions (eryth-
roleukoplakias), which may appear irregularly flat or nodular, and are subdivided 
into a variety of subtypes, such as erythematous or speckled, nodular and verrucous 
(Figure 2). Verrucous leukoplakia, one of the most misdiagnosed subtypes of non-
homogeneous leukoplakia because of its challenging clinical appearance, although 
presenting as a uniform white lesion, its verrucous texture is the characteristic 
that differentiates it from homogeneous leukoplakia (Figure 3) [10]. Proliferative 
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verrucous leukoplakia (PVL) is a very rare form and falls between nonhomo-
geneous leukoplakias and is a subtype of verrucous leukoplakia. It’s a distinct, 
 multifocal, progressive course associated with high rates of recurrence and malig-
nant transformation [4]. PVL mainly affects middle-aged women with no harmful 
habits such as smoking and presents clinically as a diffuse and homogeneous white 
Figure 1. 
Homogeneous leucoplakia on the floor of the mouth. Source: author’s file.
Figure 2. 
Nonhomogeneous leucoplakia on the back and lateral edge of the tongue. Source: author’s file.
Figure 3. 
Exuberant verrucous leukoplakia in the alveolar ridge. Source: author’s file.
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plaque at the onset, which gradually becomes erythematous and exophytic with 
the progression of the disorder, affecting mainly the gingiva, alveolar mucosa, and 
palate (Figure 4) [4, 6, 11].
Regarding the histopathological characteristics of leukoplakia, a thick layer of 
keratin in the epithelium (hyperkeratosis) is present, with or without thickening of 
the thorny layer (acanthosis). It is still possible to observe in some leukoplakia the 
presence of hyperkeratosis with epithelial atrophy. Generally, leukoplastic lesions 
do not exhibit epithelial dysplasias, but the presence of them would be a worrying 
sign for a possible malignant transformation, a fact that is most observed among 
nonhomogeneous leukoplakias [4, 6].
The diagnosis of leukoplakia is basically by excluding other diseases or disorders 
that do not carry increased risk of malignant transformation. In order to perform an 
accurate diagnosis of leukoplakia, different levels of leukoplakia must be followed 
by certainties (factor C) that lead us from a primary clinical diagnosis to the defini-
tive diagnosis based on the histopathological examination of the lesion [4, 6].
Thus, in the van der Waal factor, C1 evidence is obtained in a single visit, in 
the first contact between the dental surgeon and patient, applying only palpation 
and inspection as the primary means for diagnosis, in addition to anamnesis to 
collect data that may make up this provisional clinical diagnosis. In the certainty 
factor C2, evidence is obtained from negative results of elimination of etiological 
factors such as mechanical irritation, during a period of follow-up of 2–4 weeks or 
in the absence of any suspicious etiological factors (definitive clinical diagnosis). 
Factor C3 is similar to C2 but complemented by incisional biopsy (provisional 
histopathological diagnosis), and C4 is the evidence obtained from surgical excision 
of the lesion followed by histopathological examination of the resected specimen 
(definitive histopathological diagnosis) [11, 12]. Performing biopsy in the diagnosis 
of leukoplakia is important because only through this examination it is possible to 
determine whether to perform the histopathological diagnosis or not of epithelial 
dysplasias, thus guiding the treatment [12].
The treatment of leukoplastic lesions is dependent on the result found in the 
histopathological examination; in this way, the treatment plan is often individual-
ized according to the histological findings, such as the degree of dysplasia found in 
the epithelium. The WHO in its latest manual for the classification of head and neck 
tumors (2017) defines dysplasias as architectural and cytological epithelial changes 
caused by an accumulation of genetic alterations associated with an increased risk 
of progression to squamous cell carcinoma. Therefore, in lesions that present mild 
dysplasia or do not present dysplasia, more conservative measures should be taken, 
Figure 4. 
Proliferative verrucous leukoplakia affecting the hard palate and alveolar ridge. Source: author’s file.
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such as clinical follow-up of the lesion every 6 months throughout life, evaluation of 
the need for new biopsies, and end of smoking [3, 10]. In leukoplakias that present 
moderate or severe dysplasia/carcinoma in situ, it is recommended that the lesion 
be removed completely, if possible, or by CO2 laser therapy. However, even with 
the surgical treatment, there appears to be no reduction in the risk of developing a 
carcinoma or even relapse of the leukoplakial lesion [6, 7, 10].
Regarding the prognosis of leukoplastic lesions, recurrence rates after any type 
of treatment can range from almost 0 to 30%, which means regular follow-up of 
patients every 6 months [10].
3. Erythroplakia
Erythroplakia is defined as “a red spot that can’t be characterized clinically or 
pathologically like any other definable disease” [4]. When a mixture of red and white 
changes occurs, this lesion would be classified as a nonhomogeneous leukoplakia called 
erythroleukoplakia [10]. Erythroplakia is multifactorial, since no isolated etiological 
factor has been evident, but several intrinsic and extrinsic etiological factors have con-
tributed to the origin of this disorder, such as smoking, alcohol consumption, candida 
infection, and even nutritional deficiencies such as iron and vitamin A deficiency [6].
Erythroplakia in comparison to leukoplastic lesions is rare and has a prevalence 
rate in South and Southeast Asia ranging from 0.02 to 0.83% but presents a high 
percentage of malignant transformation ranging from 14 to 50%, and about 90% of 
cases already present moderate or severe dysplasia/carcinoma in situ. Because of the 
high rates of malignant transformation and the presence of high-grade dysplasias, 
many specialists have already considered it a primordial clinical sign of squamous 
cell carcinoma. It is a prevalent disorder in middle-aged adults in the elderly, aged 
between 45 and 74 years, with no prevalence among the genders [6, 10, 13].
Clinically, erythroplakia presents as a well delimited, asymptomatic, reddish, 
smooth and shiny stain or plaque with a soft and velvety texture [3, 6]. If hardened 
areas are observed in the lesion, it is already indicative of the presence of a possible 
invasive carcinoma at the site. The preferred anatomical location is the floor of the 
mouth, but it can be observed anywhere in the oral cavity, such as the lip, hard 
palate, or oral mucosa [3]. The clinical presentation of a solitary lesion is consis-
tently useful to clinically differentiate erythroplakia from erosive lichen planus, 
lupus erythematosus, and erythematous candidiasis, as these lesions always appear 
bilaterally and are more or less symmetrical (Figure 5) [10].
Figure 5. 
Erythroplakia affecting palate and superior alveolar ridge. Source: author’s file.
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Histopathologically, 90% of erythroplakia present as severe epithelial dyspla-
sias/carcinomas in situ or squamous cell carcinomas. The epithelium will show no 
production of keratin and is regularly atrophic. This absence of keratin associated 
with epithelial atrophy allows the underlying microvasculature to be exposed, 
thereby elucidating the reddish coloration of the lesion. In relation to connective 
tissue, it regularly exposes chronic inflammation [9].
The diagnosis of erythroplakia, as well as leukoplakias, is made by exclusion. 
This disorder presents clinically very similar to other lesions commonly found in the 
oral cavity, such as vascular lesions, candidiasis, mucosites, and even Kaposi’s sar-
coma. Because it has so many options for differential diagnosis, as in leukoplakia, 
one can use the steps or factors of analysis guided by Isaac van der Waal (factors 
C1, C2, C3, and C4) [10]. In addition, lesions on the floor of the mouth and belly 
regions and lateral border of tongue should be biopsied, since in some anatomical 
locations, the highest rates of malignant transformation occur and the presence of 
high degree dysplasia. With the accomplishment of the biopsy, for diagnostic pur-
poses, it will be possible to verify the presence or absence of dysplasias. According 
to Neville et al. [6], 90% of the erythroplakia already present severe epithelial 
dysplasias/carcinomas in situ [9].
As in leukoplakias, the treatment plan for erythroplakia is guided by the 
definitive diagnosis obtained only after the histopathological examination. In the 
absence of dysplasia or presence of mild dysplasias, the lesion is monitored every 
6 months, and if there is any change, perform a biopsy to check if any dysplastic 
modification has occurred. In lesions presenting moderate to severe dysplasia/
carcinoma in situ, complete removal of the lesion should be done with safety 
margin. As with leukoplakia, total excision of the lesion does not guarantee that 
there is no recurrence of erythroplakia; in addition to the fact that this disorder 
already has high levels of malignant transformation, its removal does not exclude 
the likelihood of future cancerous lesions on the site or in other oral locations. 
Something that should be very clear regarding the treatment of erythroplakia 
and other PMOD is that the patient who has one of these disorders will never be 
medically released, as these must be followed for life to assess whether or not 
there was any dysplastic or even the appearance of cancerous lesions in other oral 
sites [3, 6, 10].
4. Oral lichen planus
Oral lichen planus is a chronic and systemic mucocutaneous disease often found 
in the oral cavity, but it can also affect other body parts such as the skin, nails, scalp, 
and vaginal mucosa. The British physician, Erasmus Wilson, in 1869, was the first 
to describe lichen planus, and he believed that the cause of this disorder would be 
fungal infections [6, 14]. Thus, the pathophysiology of OLP for years has been a 
mystery, but it is known that this disorder occurs due to T-cell-mediated autoim-
mune destruction of the basal cells of the epithelium. Recently it was considered 
a PMOD, after several discussions among scholars, due to the fact that the lesion 
shows a low degree of malignant transformation, around 0.5% [13, 14].
The etiological factors for this disorder are still unknown, but it is believed to be 
related to stress, anxiety, diabetes, autoimmune diseases, and genetic predisposi-
tion [15]. Stress and anxiety may not have total influence on the pathogenesis of 
lichen planus, but it has been observed that patients with this disorder are usually 
subjected to high levels of stress [6].
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Oral lichen planus affects between 0.5 and 2% of the population, having a pre-
dilection for women between the ages of 30 and 60 years, being a rare disorder in 
children [6, 15]. The main intraoral sites of lichen planus are the jugal mucosa, tongue, 
and gingiva. An important feature of this lesion is bilaterality and symmetry [14].
Clinically, oral lichen planus is characterized by six distinct forms: reticular, 
erosive, bullous, plaque, papular, and atrophic, with reticular and erosive forms 
being the most prevalent. The reticular OLP is routinely present in the posterior 
jugal mucosa bilaterally. Other anatomical areas may be affected, such as the lateral 
border and back of the tongue, gingiva, palate, and vermilion lips [6, 15]. This 
type of OLP is much more common than erosive, but the latter is the most studied 
because it is symptomatic, which leads more patients to seek treatment special-
ists [6]. The reticular type is thus defined by its appearance of intertwined and 
asymptomatic white striations, the pathognomonic sign of the disorder being the 
Wickham striae (Figure 6). In the erosive type, erythematous and atrophic areas 
are observed, with varying degrees of central ulceration, and at the periphery of 
the atrophic regions, fine irradiated white streaks are usually observed (Figure 7) 
[6, 14, 15]. If the erosive state is aggravated, a separation between the epithelium 
and the underlying connective tissue may occur, resulting in a rare clinical presen-
tation of oral bullous lichen planus [6].
Figure 6. 
Lichen planus on jugal mucosa, showing Wickham striations. Source: author’s file.
Figure 7. 
Erosive lichen planus on jugal mucosa. Source: author’s file.
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Lichen planus has typical histopathological characteristics, but they are 
not specific for the lesion. Its epithelium has varying degrees of orthokeratosis 
and parakeratosis, and depending on whether the lesion is reticular or erosive, 
the thickness of the thorny layer may vary. Epithelial ridges may be absent, 
atrophic, or hyperplastic but usually exhibit sharp, serrate-like progressions. 
Another striking feature is the presence of hydropic degeneration, that is, the 
destruction of the basal cell layer of the epithelium and an intense infiltration 
of banded inflammatory cells predominantly composed of T lymphocytes. 
Some lesions of lichen planus may show some degree of dysplasia, being able to 
present aberrant mitoses and nuclear and cellular pleomorphisms, among other 
dysplastic alterations [6, 16].
The diagnosis of OLP is basically made by clinical findings, mainly in the 
reticular type, by the presence of the pathognomonic signal (Wickham striae). 
In addition to the clinical diagnosis, the histopathological examination may be 
requested for a definitive diagnosis. One thing that can make it difficult to diagnose 
OLP is the existence of candidiasis overlapping with lichen lesion, and for this, it 
is recommended that the treatment for candidiasis be carried out first and only 
subsequently the definitive diagnosis of OLP and the respective treatment plan of 
the same [6, 15].
As the reticular type does not present symptoms, there is no need for specific 
treatment, but as already mentioned, candidiasis can occur overlapping with 
lesions of lichen planus; in this way it is proposed that the antifungal treatment be 
performed based on topical nystatin, and mouthwash with nystatin or application 
of Miconazole gel is recommended. In erosive lichen planus, because it has painful 
symptomatology, treatment with topical corticosteroids initially, such as triam-
cinolone acetonide and beclomethasone, is suggested. The second line of treatment 
would be the use of retinoids, cyclosporine, and calcineurin inhibitors prescribed 
for about 2 weeks. In addition to drug treatment, photodynamic therapy is usu-
ally used to relieve symptoms [6, 13]. Lastly, patients with this disorder should be 
evaluated periodically for 3–6 months, especially in atypical cases with some degree 
of dysplasia [6].
5. Queilite actinic
Actinic cheilitis is a PMOD that frequently presents in vermilion of the lower 
lip, attributed to modifications in the keratinocytes of the labial mucosa. The 
expression cheilitis was first used in 1923, meaning inflammation on the lips, 
being multicausal, which include prolonged exposure to solar UV rays, allergic 
reactions, and systemic diseases. The term actinic refers to changes generated by 
radiant energy [6, 17, 18]. The etiopathogenesis of this disorder is multifactorial, 
but it is undeniable that the main etiological factor associated with actinic cheilitis 
lesions is prolonged exposure to the sun’s rays, with UV radiation and with its 
wavelength of 200–400 nm acting as a carcinogenic factor, as it can cause cell 
damage, thereby generating mutations in the DNA and tumor suppressor genes, 
especially in the p53 gene. Lately, other risk factors have been associated with 
actinic cheilitis, such as smoking, immunosuppression, chronic lupus, and lichen 
planus [17, 18].
This disorder occurs in light-skinned individuals exposed for long periods 
to solar UV rays, which is more common in men and those performing outdoor 
work, such as rural and construction workers, or have a history of progres-
sive exposure in the sun. The lesions mainly affect individuals in the age range 
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between 50 and 70 years. As previously mentioned, the primary anatomical site is 
the lower lip, and this is due to the fact that its epithelium is thinner, has a discrete 
layer of keratin, has fewer melanocytes, and receives direct radiation. Actinic 
cheilitis has a malignant transformation rate of 17%, with squamous cell carci-
noma growing gradually, and metastasis occurs only in the late stages of the lesion 
[3, 6, 16, 19].
This disorder develops slowly, and the first noticeable clinical changes are 
atrophy of the border of vermilion of the lower lip, exhibiting a smooth surface 
with spots of whitish staining. As the lesion progresses, the margin between the 
vermilion area and the cutaneous portion of the lip is erased. In more advanced 
states, rough areas with the presence of ulceration can be observed, in addition to 
the association with leukoplastic lesions. In these late states, in many cases, clinical 
signs may already be found that indicate malignant transformation, such as recur-
rent ulcers which do not heal (Figure 8) [3, 6, 17].
Actinic cheilitis can histologically be characterized by the presence of an atrophic 
stratified epithelium, hyperkeratinization, atrophy, or thickening of the thorny layer 
and varying degrees of epithelial dysplasia. In the underlying connective tissue, it is 
possible to observe an infiltration of chronic inflammatory cells and also collagenous 
bundles exhibiting basophilic changes resulting from the change from an eosino-
philic collagen to a basophilic granular material, called solar elastosis [3, 6, 17].
The diagnosis of actinic cheilitis is basically clinical; because it is a very char-
acteristic lesion, patients usually report a nonelastic sensation of the lips, followed 
by dryness and increase of volume; besides, the accomplishment of the incisional 
biopsy is mandatory mainly for its high rate of malignant transformation and also to 
propose a suitable treatment plan for the lesion. In the absence of dysplasias or pres-
ence of mild dysplasia, the use of 5-fluorouracil (Efudix®), which can be applied 
twice a day for 2–4 weeks, is recommended. Cryotherapy, which consists in freezing 
a tissue area to potentiate cell destruction without damaging the healthy tissues 
around the lesion, and the use of laser therapy are possible therapeutic alternatives. 
In the occurrence of moderate or severe dysplasia/carcinomas in situ, a vermilion-
ectomy is indicated, the affected vermilion mucosa is removed, and the vermilion 
reconstruction of the lip occurs from the internal labial mucosa [3, 6, 17, 19]. In addi-
tion, all patients with actinic cheilitis should be directed to use sunscreens and other 
forms of protection against UV rays; thus, in the same way as with other PMODs, 
individuals who have actinic cheilitis should be monitored routinely throughout life.
Figure 8. 
Actinic cheilitis in the lower lip exhibiting epithelial atrophy and loss of sharpness of the demarcation line 
between the labial mucosa and the epidermis. Source: author’s file.
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6. Oral submucous fibrosis
Oral submucous fibrosis is a chronic disorder of the mucosa that lines the upper 
digestive tract that surrounds the oral cavity, oropharynx, and routinely the upper 
third of the esophagus, and is often found in individuals living in Southwest Asian 
countries [6, 13]. Before the etiology of this disorder was considered multifactorial 
and complex, it is now recognized that its appearance is due to the chewing of areca 
nut; this sachet is composed of areca palm nut and hydrated lime, sometimes with 
sweeteners and condiments, wrapped in a betel leaf [6, 20]. Because this custom is 
common in Southwest Asia, the highest frequency of this disorder is in the population 
of this region, mainly in India. Its frequency is about 0.5% in the population, and 
estimates suggest that about 2.5 million people are affected. The predominant age 
group is between 20 and 40 years, since the rural villagers begin the habit of chewing 
areca nuts very early and for long periods of time, around 16 hours. Oral submucous 
fibrosis has a malignant transformation rate between 2.3 and 7.6% [3, 11, 19].
Initially oral submucous fibrosis presents as vesicles and ulcers, often on the 
hard palate and buccal mucosa. With the progression of the disorder, the patient 
may present with xerostomia, difficulty in moving the tongue, and decreased elas-
ticity of the oral mucosa, lips, and floor of the mouth, and some patients may report 
oral burning sensation. On palpation examination, dense fibrous bands may be felt, 
and a change in the color of the buccal mucosa with whitish and opaque tones. In 
the final stage, generalized fibrosis of the oral cavity and progressing trismus are 
observed [14].
Histologically, oral submucous fibrosis is described as a submucous deposition 
of dense collagenous connective tissue that shows little presence of blood vessels 
but with large numbers of chronic inflammatory cells. In lesions in soft states, the 
present epithelial alterations are subepithelial vesicles, whereas in lesions in more 
advanced states, it is possible to observe epithelial atrophy and hyperkeratosis. In 
addition, about 10–15% of FSO lesions present some level of dysplasia and even 
present carcinoma in situ [6].
The diagnosis is based on clinical findings and confirmed by biopsy and subse-
quent histopathological examination. There is no specific treatment for oral submu-
cous fibrosis, but it is imperative that the diagnosed individual ceases the harmful 
habits. However, it is important to note that the lesion will not regress only with the 
removal of the habit, but it will prevent a possible malignant transformation. In 
patients who have mild or moderate cases of the disorder, treatment with cortico-
steroids applied to the lesion is recommended in order to reduce the symptoms. For 
later stages, surgical therapy is the most recommended, aiming to relieve trismus 
by releasing fibrous tissue through conventional techniques of tissue reconstruc-
tion, covering local/regional advancement flaps and microvascular flaps. Other 
treatment options include iron and multivitamin supplements and intralesional 
injections of lycopene alone or in combination with steroids, and some studies 
have shown the efficacy of interferon use for improved mouth opening [6, 11, 14, 
19, 20]. Patients with oral submucous fibrosis are at least 19 times more likely to 
develop squamous cell carcinoma than individuals who do not have squamous cell 
carcinoma that even after the treatment for the symptomatology of the disease, the 
patients should be monitored routinely [6].
7. Conclusion
Potentially malignant oral disorders are the first indications of micro- and 
macroscopic alterations of possible malignant transformations, so knowledge about 
11
Potentially Malignant Oral Disorders
DOI: http://dx.doi.org/10.5772/intechopen.88580
these lesions is of great importance for specific care and prevention against any 
type of carcinoma. The transformation of normal mucosa to dysplastic mucosa 
occurs through a complex set of interactions between the individual’s organism and 
environmental factors. Risk factors involving PMOD such as sun exposure, smoking 
habits, alcohol ingestion, and infection by microorganisms are issues that need to 
be addressed in order to better treat, prevent, and reduce malignant transformation 
rates. Thus, it is suggested that clinicians design educational plans aimed at the 
prevention of PMOD, as well as possible malignant transformations, in this way, 
enabling their patients against exposure to the causal factors of the disorders. In 
summary, the diagnosis and treatment plan for potentially malignant oral disorders 
are fundamental, since lesions that have high degrees of dysplasia should be treated 
with surgical procedures and those with no or slight degrees of dysplasia should 
undergo conservative treatments, such as drug therapy or phototherapy.
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